Stanislav I. Sitkin

Saint Petersburg, SPE 197341, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Autoprobiotic Supplements Attenuate Obesity and Improve Gut Microbiota, Carbohydrate, and Lipid Metabolism in Patients with Metabolic Syndrome: A Pilot Trial.

Autoprobiotic Supplements Attenuate Obesity and Improve Gut Microbiota, Carbohydrate, and Lipid Metabolism in Patients with Metabolic Syndrome: A Pilot Trial.

Journal: Nutrients

Published: April 01, 2026

Maternal Gut Microbiome as a Predictor of Insulin Therapy Requirement in Gestational Diabetes.

Maternal Gut Microbiome as a Predictor of Insulin Therapy Requirement in Gestational Diabetes.

Journal: Journal of diabetes science and technology

Published: March 04, 2026

Health Reversion Effects of Autoprobiotics on Serum and Urine Metabolomes in Patients With Metabolic Syndrome: A Pilot Study.

Health Reversion Effects of Autoprobiotics on Serum and Urine Metabolomes in Patients With Metabolic Syndrome: A Pilot Study.

Journal: Molecular nutrition & food research

Published: April 28, 2025

An early post-birth immune-microbiota landscape predicts the development of necrotizing enterocolitis in term newborns with congenital heart defects.

An early post-birth immune-microbiota landscape predicts the development of necrotizing enterocolitis in term newborns with congenital heart defects.

Journal: Scientific reports

Published: February 04, 2025

The microbiome in endometrial cancer: vaginal milieu matters.

The microbiome in endometrial cancer: vaginal milieu matters.

Journal: Frontiers in medicine

Published: December 02, 2024

Personalized prediction of glycemic responses to food in women with diet-treated gestational diabetes: the role of the gut microbiota.

Personalized prediction of glycemic responses to food in women with diet-treated gestational diabetes: the role of the gut microbiota.

Journal: NPJ biofilms and microbiomes

Published: August 02, 2024

He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome.

He who controls Clostridia and Bacteroidia controls the gut microbiome: The concept of targeted probiotics to restore the balance of keystone taxa in irritable bowel syndrome.

Journal: Neurogastroenterology and motility

Published: March 25, 2024

Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-modulating Therapy for Inflammatory Bowel Disease.

Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-modulating Therapy for Inflammatory Bowel Disease.

Journal: Inflammatory bowel diseases

Published: September 06, 2023

Evaluation of the effectiveness of personalised therapy for the patients with irritable bowel syndrome.

Evaluation of the effectiveness of personalised therapy for the patients with irritable bowel syndrome.

Journal: Beneficial microbes

Published: March 27, 2023

Helicobacter pylori and Inflammatory Bowel Disease: An Unresolved Enigma.

Helicobacter pylori and Inflammatory Bowel Disease: An Unresolved Enigma.

Journal: Inflammatory bowel diseases

Published: December 14, 2022

Necrotizing Enterocolitis: The Role of Hypoxia, Gut Microbiome, and Microbial Metabolites.

Necrotizing Enterocolitis: The Role of Hypoxia, Gut Microbiome, and Microbial Metabolites.

Journal: International journal of molecular sciences

Published: October 19, 2022

Intestinal microbiome changes in an infant with right atrial isomerism and recurrent necrotizing enterocolitis: A case report and review of literature.

Intestinal microbiome changes in an infant with right atrial isomerism and recurrent necrotizing enterocolitis: A case report and review of literature.

Journal: World journal of clinical cases

Published: February 16, 2022

Showing 1-12 of 56

Last Updated: 09/26/2026